Skip to main content

Table 1 Baseline characteristics of study population

From: Study of T Cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART

  Effective Group Ineffective Group Untreated Group Control Group
Number of Subjects 25 18 17 15
Sex     
   Male 19(76%) 13(72.2%) 13(76.5%) 9(60%)
   Female 6(24%) 5(27.8%) 4(23.5%) 6(40%)
Age 47.6 ± 9.1 45.7 ± 10.4 39.7 ± 11.3 40.5 ± 9.7
  (35~71) (31~60) (36~63) (33~57)
Transmission     
   Sexual 21(84%) 16(88.8%) 16(94.1%) --
   Blood 3(12%) 1(5.6%) 1(5.9%) --
   Other 1(4%) 1(5.6%) 0 --
CD4+ T (cells/[μL) * 187 175 341 736
  (22~367) (56~341) (78~400) (452~1038)
   < 200 13(52%) 10(55.6%) 2(11.8%) 0
   ≥ 200~ < 350 11(44%) 8(44.4%) 5(29.4%) 0
   ≥ 350 1(4%) 0 10(58.8%) 15(100%)
Therapy     
   2NRTIs+NNRTI 13(52%) 11(61.1%) -- --
   2NRTIs+PI 12(48%) 7(38.9%) -- --
  1. *: baseline CD4+ T cell counts are shown by medians with ranges. NRTI: Nucleoside Reverse Transcriptase Inhibitor, NNRTI: Non-nucleoside Reverse Transcriptase Inhibitor, PI: Protease Inhibitor.